Abstract
Journal of Hematology & Oncology is pleased to see the exponential growth in the number of publications from China, especially in hematology and oncology. This editorial calls for putting more weight on the quality of the future scientific output and invites rigorous dialogs among policy makers, granting agencies, academic leaders, physicians, and scientists, followed by concrete actions, to achieve such a goal.
Similar content being viewed by others
Editorial
The number of scientific publications from China has exploded in the past 10 years. Multiple factors have propelled this exponential growth. Among these factors include but are not limited to a large scientific research base, increases in government funding through Natural Science Foundation of China, acute upholding of the publish-or-perish mantra, monetary reward for publications from local institutions, institutional requirement for publications in quality journals for awarding doctoral degrees, and faculty promotions. Dr. An-mei Deng’s group from Shanghai performed a detailed and focused analysis of hematology research output from China in the past 10 years [1]. The study compared and contrasted the quantities and qualities of publications from China with those from the United States, Great Britain, Germany, Japan, and South Korea. It is clear that China has become a high output country of scientific publications in the international journals, yet the quality disproportionally lagged behind.
China has succeeded in quantitative promotion of scientific research [2]. The next step is to focus on improving quality. This will require time and patience. To achieve this goal, it is imperative to continue to reform the education system to place the greatest emphasis on originality and creativity of the scientific endeavor in both clinical and basic research. A conducive environment must be preserved to put more weight on the quality of research rather than publication number in measuring scientific output. Funding decisions shall also be made not based on the trending topics in the field but strategically on nurturing the growth of scientific leaders and allowing time for high quality researches to mature. Even though the return of many top scientists to China from the United States and other countries has clearly enhanced the quality of scientific publications, cultivation of homegrown scientific leaders is the only sustainable way for China to lead in the scientific world.
References
Zhang L, Ye X, Sun Y, Deng A-M, Qian B-H. Hematology research output from Chinese authors and other countries: a 10-year survey of the literature. J Hematol Oncol. 2015;8(1):8.
Xie Y, Zhang C, Lai Q. China’s rise as a major contributor to science and technology. Proc Natl Acad Sci USA. 2014;111(26):9437–42.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Liu, D., Sun, W., Hou, J. et al. Pass quantity, focus on quality. J Hematol Oncol 8, 27 (2015). https://doi.org/10.1186/s13045-015-0123-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13045-015-0123-7